News

Midlife PSA measure predicted lethal prostate cancer

Publish date: May 20, 2014

 

AT THE AUA ANNUAL MEETING

Dr. Preston reported having no disclosures. Dr. Eggener has been a consultant, adviser, lecturer, investigator, and/or proctor for Genomic Health, Intuitive Surgical Janssen Pharmaceuticals, and Myriad Genetics.

Pages

Recommended Reading

First SEER analysis including HER2 subtype is reported
MDedge Family Medicine
Topical tazarotene did not improve response to imiquimod 5% in lentigo maligna
MDedge Family Medicine
EndoRings-assisted colonoscopy hikes polyp, adenoma detection
MDedge Family Medicine
Polyp, adenoma detection rises with Endocuff device
MDedge Family Medicine
Delaying ADT for PSA-only prostate cancer relapse appears safe
MDedge Family Medicine
Obesity increased breast cancer mortality only in premenopausal women
MDedge Family Medicine
Low-dose CT could up early lung cancer detection - at a price
MDedge Family Medicine
Lesion on side of tongue
MDedge Family Medicine
Childhood cancer survivors: Less frequent heart screening may be more cost effective
MDedge Family Medicine
Registry data: No increase in prostate cancer risk with long-term TRT
MDedge Family Medicine